PROPEL represents a medical breakthrough clinically proven to improve surgical outcomes for chronic sinusitis sufferers.

PROPEL is the first and only device clinically shown to keep the sinuses open after surgery, precisely deliver anti-inflammatory medication directly into the healing tissues, and then dissolve.

The innovative sinus stent decreases post-operative scarring and inflammation, reducing the need for additional surgical procedures as well as oral steroids and their potential side effects. At the same time, PROPEL’s spring-like, lightweight design means patients usually cannot even tell that it is there.

Sinusitis is among the most common diagnoses for those who visit their physician complaining of coughing, sinus pressure, congestion, postnasal drainage and headaches. One in eight adults suffers from sinusitis today. Often, patients misdiagnose themselves as simply suffering from seasonal allergies or a persistent cold. While medications such as nasal sprays, antibiotics and antihistamines can provide temporary relief, many times they do not solve the problem and a surgical procedure may be required

Dr. Michael Bublik is now placing the dissolvable PROPEL Sinus Stent at the end of surgery. The lightweight stent helps keep the sinus cavities open after surgery and steadily delivers local anti-inflammatory medication to the healing sinus tissue.

The PROPEL Stent improves patient outcomes and the healing process, plus patients hardly know it is there.

The PROPEL Stent is carefully inserted by Dr. Michael Bublik into the sinus cavity at the end of surgery. The stent remains there for a few weeks, utilizing a spring-like mechanism to open up the nasal passageway. At the same time, it provides anti-inflammatory therapy to enhance healing. The stent slowly dissolves on its own, and no removal is necessary, making postoperative care easier on patients.

PROPEL has been studied in three prospective, randomized clinical trials conducted in the United States demonstrating reduced scarring and reduced need for oral steroids.

When a patient’s chronic sinusitis does not respond to medications, surgery to enlarge the opening to drain the sinuses may provide the best option. The PROPEL Sinus Stent offers a new weapon in the fight against chronic sinusitis, backed by clinical data and positive outcomes.

DESIGN. ARTISTRY. EXPERIENCE.

Dr. Michael Bublik is a triple board-certified fellowship-trained facial plastic surgeon. Dr. Bublik is often sought after for not only primary or first-time rhinoplasty but also revision rhinoplasty. This is due to his extensive training with some of the best rhinoplasty surgeons in the world. He brings with him years of experience and the experience of being involved in thousands of rhinoplasty cases.